You are here

Article info

Article menu
Download PDFPDF
Neurodegeneration
Research paper
Parkinson’s disease: evolution of cognitive impairment and CSF Aβ1–42 profiles in a prospective longitudinal study

Authors

  • Stefanie Lerche Center of Neurology, Department of Neurodegeneration and Hertie-Institute for Clinical Brain Research, University of Tuebingen, Tuebingen, Germany German Center for Neurodegenerative Diseases, University of Tuebingen, Tuebingen, Germany PubMed articlesGoogle scholar articles
  • Isabel Wurster Center of Neurology, Department of Neurodegeneration and Hertie-Institute for Clinical Brain Research, University of Tuebingen, Tuebingen, Germany German Center for Neurodegenerative Diseases, University of Tuebingen, Tuebingen, Germany PubMed articlesGoogle scholar articles
  • Benjamin Röben Center of Neurology, Department of Neurodegeneration and Hertie-Institute for Clinical Brain Research, University of Tuebingen, Tuebingen, Germany German Center for Neurodegenerative Diseases, University of Tuebingen, Tuebingen, Germany PubMed articlesGoogle scholar articles
  • Gerrit Machetanz Center of Neurology, Department of Neurodegeneration and Hertie-Institute for Clinical Brain Research, University of Tuebingen, Tuebingen, Germany German Center for Neurodegenerative Diseases, University of Tuebingen, Tuebingen, Germany PubMed articlesGoogle scholar articles
  • Milan Zimmermann Center of Neurology, Department of Neurodegeneration and Hertie-Institute for Clinical Brain Research, University of Tuebingen, Tuebingen, Germany German Center for Neurodegenerative Diseases, University of Tuebingen, Tuebingen, Germany PubMed articlesGoogle scholar articles
  • Felix Bernhard Center of Neurology, Department of Neurodegeneration and Hertie-Institute for Clinical Brain Research, University of Tuebingen, Tuebingen, Germany German Center for Neurodegenerative Diseases, University of Tuebingen, Tuebingen, Germany PubMed articlesGoogle scholar articles
  • Elke Stransky Center of Neurology, Department of Neurodegeneration and Hertie-Institute for Clinical Brain Research, University of Tuebingen, Tuebingen, Germany PubMed articlesGoogle scholar articles
  • Christian Deuschle Center of Neurology, Department of Neurodegeneration and Hertie-Institute for Clinical Brain Research, University of Tuebingen, Tuebingen, Germany German Center for Neurodegenerative Diseases, University of Tuebingen, Tuebingen, Germany PubMed articlesGoogle scholar articles
  • Claudia Schulte Center of Neurology, Department of Neurodegeneration and Hertie-Institute for Clinical Brain Research, University of Tuebingen, Tuebingen, Germany German Center for Neurodegenerative Diseases, University of Tuebingen, Tuebingen, Germany PubMed articlesGoogle scholar articles
  • Oskar Hansson Clinical Memory Research Unit, Department of Clinical Sciences Malmö, Lund University, Malmö, Sweden Department of Neurology, Skåne University Hospital, Lund, Sweden Memory Clinic, Skåne University Hospital, Malmö, Sweden PubMed articlesGoogle scholar articles
  • Henrik Zetterberg Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, the Sahlgrenska Academy at the University of Gothenburg, Mölndal, Sweden Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Mölndal, Sweden Department of Molecular Neuroscience, UCL Institute of Neurology, Queen Square, London, UK PubMed articlesGoogle scholar articles
  • Thomas Gasser Center of Neurology, Department of Neurodegeneration and Hertie-Institute for Clinical Brain Research, University of Tuebingen, Tuebingen, Germany German Center for Neurodegenerative Diseases, University of Tuebingen, Tuebingen, Germany PubMed articlesGoogle scholar articles
  • Daniela Berg Center of Neurology, Department of Neurodegeneration and Hertie-Institute for Clinical Brain Research, University of Tuebingen, Tuebingen, Germany Department of Neurology, Christian-Albrechts University, Kiel, Germany PubMed articlesGoogle scholar articles
  • Walter Maetzler Center of Neurology, Department of Neurodegeneration and Hertie-Institute for Clinical Brain Research, University of Tuebingen, Tuebingen, Germany Department of Neurology, Christian-Albrechts University, Kiel, Germany PubMed articlesGoogle scholar articles
  • Kathrin Brockmann Center of Neurology, Department of Neurodegeneration and Hertie-Institute for Clinical Brain Research, University of Tuebingen, Tuebingen, Germany German Center for Neurodegenerative Diseases, University of Tuebingen, Tuebingen, Germany PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Stefanie Lerche, Department of Neurodegeneration, Hertie Institute for Clinical Brain ResearchUniversity of Tuebingen, Tuebingen, 72076, Germany; stefanie.lerche{at}uni-tuebingen.de
View Full Text

Citation

Lerche S, Wurster I, Röben B, et al
Parkinson’s disease: evolution of cognitive impairment and CSF Aβ1–42 profiles in a prospective longitudinal study
Journal of Neurology, Neurosurgery & Psychiatry 2019;90:165-170.

Publication history

  • Received June 5, 2018
  • Revised August 9, 2018
  • Accepted August 14, 2018
  • First published September 25, 2018.
Online issue publication 
January 16, 2019

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2019. No commercial re-use. See rights and permissions. Published by BMJ.